| Financial Year |
March 31 2023 |
| Monetary Funds |
1,873,987,265.01 |
| Held-for-trading Financial Assets |
420,000,000.00 |
| Notes Receivable |
259,446,211.29 |
| Accounts Receivable |
1,650,748,222.81 |
| Advances to Suppliers |
55,701,331.91 |
| Other Receivables |
59,363,314.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
477,871,050.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,630,911.50 |
| Total Current Assets |
5,370,441,824.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,601,395,673.98 |
| Investment Properties |
17,842,121.06 |
| Fixed Assetes |
1,348,208,917.48 |
| Under-construction Projects |
111,032,869.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,826,172.69 |
| R&D expenses |
-- |
| Goodwill |
1,785,240.82 |
| Long-Term Deferred and Prepaid Expenses |
48,758,343.68 |
| Deferred Income Tax Assets |
102,686,485.21 |
| Other Non-Current Assets |
1,755,815.11 |
| Sub-Total of Non-Current Assets |
3,442,179,113.81 |
| Total Assets |
8,812,620,938.20 |
| Short-Term Loans |
509,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
836,749,784.41 |
| Accounts Payable |
2,242,801,811.15 |
| Accounts Received In Advance |
3,484,530.45 |
| Employee Compensation Payable |
114,997,865.21 |
| Taxes Payable |
36,209,930.54 |
| Interest Payable |
418,304.68 |
| Dividend Payable |
53,585,219.15 |
| Other payables |
421,953,959.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,662,779.48 |
| Other Current Liabilities |
20,579,036.26 |
| Sub-Total of Current Liabilities |
4,228,999,089.77 |
| Long-term Loans |
238,166,486.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,146,814.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,926,807.13 |
| Deferred Income Tax Liabilities |
6,915,201.75 |
| Other Non-Current Liabilities |
15,679.22 |
| Sub-Total of Non-Current Liabilities |
444,218,835.38 |
| Total Liabilities |
4,673,217,925.15 |
| Paid-In Capital(Or Share Stock) |
470,418,905.00 |
| Capital Surplus |
1,302,266,348.42 |
| Surplus Reserve |
143,826,283.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,291,493,441.47 |
| Minority Stockholder's Interest |
953,734,985.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,185,668,027.76 |
| Owner's Equity（Stockholder's Equity） |
4,139,403,013.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,812,620,938.20 |
